Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2006-11-28
2006-11-28
Richter, Johann (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S252130, C514S269000, C514S307000, C514S317000, C514S386000, C514S389000, C544S060000, C546S208000, C548S316400
Reexamination Certificate
active
07141561
ABSTRACT:
This invention discloses and claims diary heterocycles of formula (I)and their pharmaceutically acceptable salts, pharmaceutical compositions thereof, and methods of using said compounds of formula (I) for the treatment or prevention of excessive weight or obesity, and for treatment of Type II diabetes, arteriosclerosis, high blood pressure, depression, anxiety, anxiety neuroses, and schizophrenia. Methods for treatment of excessive weight or obesity and for treatment of Type II diabetes with a mixture of a compound of formula I and antiobesity agents or appetite-regulating active ingredients, or with a mixture of a compound of formula I and antidiabetics or hypoglycemic active ingredients are also disclosed and claimed.
REFERENCES:
patent: 5276049 (1994-01-01), Himmelsbach et al.
patent: 5478942 (1995-12-01), Himmelsbach et al.
patent: 5650424 (1997-07-01), Himmelsbach et al.
patent: 6054590 (2000-04-01), Poindexter et al.
patent: 2002/0042400 (2002-04-01), Rong et al.
patent: 0002649 (1979-06-01), None
patent: 0503548 (1992-09-01), None
patent: WO 96/25410 (1996-08-01), None
patent: WO 97/26265 (1997-07-01), None
patent: WO 97/41097 (1997-11-01), None
patent: WO 98/08871 (1998-03-01), None
patent: WO 98/58934 (1998-12-01), None
patent: WO 99/03861 (1999-01-01), None
patent: WO 02/10146 (2002-02-01), None
patent: WO 02/10141 (2002-07-01), None
patent: WO 02/051819 (2002-07-01), None
patent: WO 03/057220 (2003-07-01), None
Audinott Valerie et al., Structure-Activity Relationship Studies of Melanin-concentrating Hormone (MCH)-related Peptide Ligands at SLC-1, the Human MCH Receptor, J. Biol. Chem., 2001, vol. 276, No. 17, pp. 13554-13562.
Chambers Jon et al., Melanin-concentrating hormone is the cognate ligand for the orphan G-protein-coupled receptor SLC-1, Nature, 1999, vol. 400, pp. 261-185.
Saito Yumiko et al., Molecular characterization of the melanin-concentrating-hormone receptor, Nature, 1999, vol. 400, pp. 265-269.
Donald J. Cram et al., Host-Guest Complexation. 31. A Transacylase Partial Mimic, J. Am. Chem. Soc. (1984, pp. 4987-5000, vol. 106).
Jon Chambers et al., Melanin-concentrating hormone is the cognate ligand for the orphan G-protein-coupled receptor SLC-1, Letters to Nature (1999, pp. 261-265, vol. 400).
Kent D. Stewart et al., Host-Guest Complexation. 40. Synthesis And Complexation of Macrocyclic Hosts Containing Cyclic Ureas, Anisyls, and Steric Barriers, The Journal of Organic Chemistry (1986, pp. 4327-4337, vol. 51, No. 23).
Roeland J. M. Nolte et al., Host-Guest Complexation. 27. Hosts Containing Only Cyclic Urea Binding Sites, J. Am. Chem. Soc. (1984, pp. 1416-1420, vol. 108).
Saito Yumiko et al., Molecular characterization of the melanin-concentrating-hormone receptor, Letters to Nature, (1999, pp. 265-269, vol. 400).
Valerie Audinot et al., Structure-Activity Relationship Studies of Melanin-concentrating Hormone (MCH)-related Peptide Ligands at SLC-1, the Human MCH Receptor, The Journal of Biological Chemistry (2001, pp. 13554-13562, vol. 276, No. 17).
Boehme Thomas
Gossel Matthias
Hessler Gerhard
Rosse Gerard
Schwink Lothar
Gupta Balaram
Martin Lawrence L.
Richter Johann
Sackey Ebenezer
Sanofi-Aventis Deutschland GmbH
LandOfFree
Substituted diaryl heterocycles, process for their... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted diaryl heterocycles, process for their..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted diaryl heterocycles, process for their... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3631912